LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | R406 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2945 | 3228 | 0.9124 | 0.8770 |
Hs 578T | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 929 | 2257 | 3228 | 0.6993 | 0.5777 |
Hs 578T | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3182 | 3228 | 0.9857 | 0.9800 |
Hs 578T | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 929 | 1445 | 3228 | 0.4478 | 0.2247 |
Hs 578T | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 929 | 1412 | 3228 | 0.4374 | 0.2100 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 929 | 2877 | 3228 | 0.8915 | 0.8476 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2554 | 3228 | 0.7912 | 0.7068 |
Hs 578T | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 929 | 3131 | 3228 | 0.9701 | 0.9581 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 929 | 1291 | 3228 | 0.4001 | 0.1577 |
Hs 578T | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 929 | 2504 | 3228 | 0.7757 | 0.6850 |
Hs 578T | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 929 | 2312 | 3228 | 0.7164 | 0.6018 |
Hs 578T | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 929 | 2910 | 3228 | 0.9015 | 0.8616 |
Hs 578T | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 929 | 3045 | 3228 | 0.9433 | 0.9204 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3189 | 3228 | 0.9880 | 0.9832 |
Hs 578T | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 929 | 3394 | 3228 | 1.0514 | 1.0722 |
Hs 578T | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2955 | 3228 | 0.9154 | 0.8812 |
Hs 578T | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3124 | 3228 | 0.9679 | 0.9549 |
Hs 578T | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 929 | 3017 | 3228 | 0.9346 | 0.9082 |
Hs 578T | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3121 | 3228 | 0.9669 | 0.9536 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 3137 | 3228 | 0.9718 | 0.9604 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 929 | 1017 | 3228 | 0.3151 | 0.0382 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 929 | 941 | 3228 | 0.2916 | 0.0053 |
Hs 578T | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2641 | 3228 | 0.8183 | 0.7449 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 2706 | 3228 | 0.8385 | 0.7732 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 3674 | 3228 | 1.1381 | 1.1940 |